Colonoscopy: Practice Patterns and Limitations
结肠镜检查:实践模式和局限性
基本信息
- 批准号:7745498
- 负责人:
- 金额:$ 26.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAge-YearsAreaBenignCaucasoid RaceCharacteristicsColonic AdenomaColonic PolypsColonoscopyColorectalColorectal CancerColorectal PolypDataDatabasesDetectionDevelopmentDiagnosisDiagnostic Neoplasm StagingEarly treatmentEffectivenessExcisionFrequenciesFutureGeneral PopulationGoalsGuidelinesHealth PlanningIncidenceKnowledgeLesionLinkMalignant - descriptorMalignant NeoplasmsMeasuresMedicareMedicare claimOperative Surgical ProceduresOutcomePatientsPatternPhasePhysiciansPoliciesPolypectomyPolypsPopulationPremalignantProceduresRandomized Controlled TrialsRecording of previous eventsRectumRegistriesRelative (related person)RiskRisk FactorsSamplingScreening procedureSpecialistSpecific qualifier valueStagingTestingTimeTreatment outcomeUse Effectivenessbasebeneficiarycancer recurrenceclinical practicecohortcolorectal cancer screeningdesignfollow-upindexingmedical specialtiespopulation basedprospectivepublic health relevanceroutine practice
项目摘要
DESCRIPTION (provided by applicant): Colonoscopy is considered by many professional and lay groups to be the preferred option for colorectal cancer screening and by virtue of polypectomy, it allows removal of premalignant lesions and possibly curative treatment of early stage cancers. Despite the positive attributes of screening colonoscopy, because of development of interval cancers following colonoscopy, concerns about the accuracy of colonoscopy as currently practiced have been raised. It also appears that there is relative overuse of the procedure for follow up after polyp removal. There is a relative paucity of population-based data regarding colonoscopy utilization and outcomes. The proposed study will include two components, one using a cancer-free population and one using patients with incident colorectal cancer. In the first phase, a cohort of patients undergoing colonoscopy with polypectomy will be identified through a 5% random sample of Medicare claims data. Previous claims will be searched to stratify according to a prior history of colon polyps or other risk factors, or colonic surgery. Following the index polypectomy, claims will be examined to determine the timing and outcome of repeat colonoscopy and other colonic procedures, with a particular focus on colonoscopies performed before the 3-year minimum interval. Practice patterns will be compared between patient, physician and facility characteristics. In the second phase, patients with a first diagnosis of colorectal cancer will be identified through SEER registry files. Among patients with a polyp containing early stage cancer, the outcome of treatment with endoscopic resection will be compared to surgical resection, and delayed outcomes, including the need for subsequent surgery will be measured. Factors that predict the use of endoscopic resection will be identified and propensity scores for treatment will be developed and used to compare outcomes. Among all patients with incident cancer, prior claims data will be searched to determine the use of colonoscopy. A cohort of patients with potentially missed or interval cancer will be identified and compared to other patients according to patient, physician, facility, and small area characteristics. The studies proposed in this application will provide important data about the use and potential effectiveness of colonoscopy in routine practice. Given the increased emphasis on colonoscopy as a preferred screening test in the general population, these data will help inform future policy decisions. PUBLIC HEALTH RELEVANCE: Colorectal cancer, the second most fatal cancer in the U.S., is largely preventable through the removal of polyps. However, there is only limited knowledge about the treatment and outcome of colorectal polyps in routine clinical practice. Using data from a large number of Medicare patients, we will study practice patterns for polyp removal via colonoscopy, evaluate its effectiveness in the treatment of early stage colorectal cancer, and estimate the potential failed detection rate at colonoscopy.
描述(由申请人提供):许多专业和外行人组认为结肠镜检查是结直肠癌筛查的首选选择,并依靠多型切除术,它允许去除预抗病变的病变,并可能治疗早期阶段癌症的治疗方法。尽管结肠镜检查具有筛查的积极属性,但由于结肠镜检查后间隔癌的发展,人们对目前实践的结肠镜检查的准确性的担忧已经提高。看来,息肉去除后的过程相对过度使用。关于结肠镜检查和结果的基于人群的数据相对匮乏。拟议的研究将包括两个组成部分,一个使用无癌症的人群,另一种使用入射结直肠癌的患者。在第一阶段,将通过5%的Medicare索赔数据进行5%的随机样本来鉴定进行结肠镜检查的患者队列。将根据结肠息肉或其他危险因素或结肠手术的先前史进行以前的索赔进行分层。索引多型切除术后,将检查索赔,以确定重复结肠镜检查和其他结肠手术的时间和结果,并特别关注在最小三年最小间隔之前进行的结肠镜检查。将在患者,医师和设施特征之间比较练习模式。在第二阶段,将通过SEER注册表文件确定有结直肠癌的患者。在含有早期癌症的息肉的患者中,将将内窥镜切除治疗的结果与手术切除术进行比较,并将结局延迟,包括后续手术的需求。将确定预测使用内窥镜切除术的因素,并将开发和用于比较结果的倾向分数。在所有入射癌症患者中,将搜索先验索赔数据以确定结肠镜检查的使用。根据患者,医师,设施和小面积特征,将确定一群潜在丢失或间隔癌症的患者并将其与其他患者进行比较。本应用程序中提出的研究将提供有关结肠镜检查在常规实践中的使用和潜在有效性的重要数据。鉴于对一般人群的首选筛查测试的重视日益强调,这些数据将有助于为未来的政策决策提供信息。 公共卫生相关性:大肠癌是美国第二大致命癌,在很大程度上可以通过去除息肉来预防。但是,在常规临床实践中,关于结直肠息肉的治疗和结果的知识有限。使用来自大量Medicare患者的数据,我们将研究通过结肠镜检查去除息肉的实践模式,评估其在早期结直肠癌治疗中的有效性,并估计结肠镜检查时的潜在检测率失败。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY S. COOPER其他文献
GREGORY S. COOPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY S. COOPER', 18)}}的其他基金
Detection of Advanced Adenoma Via Stool DNA (sDNA) Methylation Testing
通过粪便 DNA (sDNA) 甲基化检测检测晚期腺瘤
- 批准号:
8555228 - 财政年份:2011
- 资助金额:
$ 26.06万 - 项目类别:
Colonoscopy: Practice Patterns and Limitations
结肠镜检查:实践模式和局限性
- 批准号:
8009517 - 财政年份:2009
- 资助金额:
$ 26.06万 - 项目类别:
Colonoscopy: Practice Patterns and Limitations
结肠镜检查:实践模式和局限性
- 批准号:
7581321 - 财政年份:2009
- 资助金额:
$ 26.06万 - 项目类别:
Large Database Research for Cancer Prevention & Control
癌症预防的大型数据库研究
- 批准号:
6835211 - 财政年份:2002
- 资助金额:
$ 26.06万 - 项目类别:
Large Database Research for Cancer Prevention & Control
癌症预防的大型数据库研究
- 批准号:
6692981 - 财政年份:2002
- 资助金额:
$ 26.06万 - 项目类别:
Large Database Research for Cancer Prevention & Control
癌症预防的大型数据库研究
- 批准号:
6430632 - 财政年份:2002
- 资助金额:
$ 26.06万 - 项目类别:
Large Database Research for Cancer Prevention & Control
癌症预防的大型数据库研究
- 批准号:
7010009 - 财政年份:2002
- 资助金额:
$ 26.06万 - 项目类别:
Large Database Research for Cancer Prevention & Control
癌症预防的大型数据库研究
- 批准号:
6621135 - 财政年份:2002
- 资助金额:
$ 26.06万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Prospective study of bilingualism and cognitive reserve in the aging brain of Hispano adults with MCI
患有 MCI 的西班牙成年人衰老大脑中的双语和认知储备的前瞻性研究
- 批准号:
10584166 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别:
Promoting cognitive resilience and reducing frailty in older Veterans with bright light therapy
通过强光疗法提高老年退伍军人的认知能力并减少虚弱
- 批准号:
10590503 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别:
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别:
Resource Center for Alzheimer's and Dementia Research in Asian and Pacific Americans
亚太裔美国人阿尔茨海默病和痴呆症研究资源中心
- 批准号:
10730059 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别: